Angiostrongylus meningoencephalitis: Survival from minimally conscious state to rehabilitation

Medical Journal of Australia

Volumn 198, Issue 8, 2013, Pages 440-442

  Blair, Nicholas F ^a   Orr, Carolyn F ^b   Delaney, Anthony P ^a   Herkes, Geoffrey K ^c  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b MACQUARIE UNIVERSITY HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; DEXAMETHASONE; GLUCOSE; HYDROCORTISONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; ANGIOSTRONGYLIASIS; ANGIOSTRONGYLUS CANTONENSIS; ANGIOSTRONGYLUS MENINGOENCEPHALITIS; ARTICLE; ARTIFICIAL VENTILATION; BRAIN DISEASE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; DRUG MEGADOSE; DYSESTHESIA; ELECTROENCEPHALOGRAM; ENDOTRACHEAL INTUBATION; EOSINOPHILIA; GUILLAIN BARRE SYNDROME; HUMAN; HYDROCEPHALUS; INSOMNIA; LEG PAIN; LIMB WEAKNESS; MALE; MENINGOENCEPHALITIS; MINIMALLY CONSCIOUS STATE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PROTEIN CEREBROSPINAL FLUID LEVEL; REHABILITATION CARE; RESPIRATORY FAILURE; SEIZURE;

ANGIOSTRONGYLUS; ANIMALS; AUSTRALIA; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; EOSINOPHILIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PERSISTENT VEGETATIVE STATE; RESPIRATION, ARTIFICIAL; YOUNG ADULT;

EID: 84877322548     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja12.11085     Document Type: Article

References (11)

1. Wang QP, Lai DH, Zhu XQ, et al. Human angiostrongyliasis. Lancet Infect Dis 2008; 8: 621-630.
2. Sawanyawisuth K, Takahashi K, Hoshuyama T, et al. Clinical factors predictive of encephalitis caused by Angiostrongylus cantonensis. Am J Trop Med Hyg 2009; 81: 698-701.
3. Chotmongkol V, Sawanyawisuth K. Clinical manifestations and outcome of patients with severe eosinophilic meningoencephalitis presumably caused by Angiostrongylus cantonensis. Southeast Asian J Trop Med Public Health 2002; 33: 231-234.
4. Prociv P, Carlisle MS. The spread of Angiostrongylus cantonensis in Australia. Southeast Asian J Trop Med Public Health 2001; 32 Suppl 2: 126-128.
5. Cooke-Yarborough CM, Kornberg AJ, Hogg GG, et al. A fatal case of angiostrongyliasis in an 11-month-old infant. Med J Aust 1999; 170: 541-543.
6. Prociv P. Parasitic meningitis. Med J Aust 1999; 170: 517-518.
7. Pryor DS, Konecny P, Senanayake SN, Walker J. First report of human angiostrongyliasis acquired in Sydney. Med J Aust 2003; 179: 430-431.
8. Diao Z, Xiao H, Wang J, et al. Identification of factors associated with clinically severe angiostrongyliasis. Am J Trop Med Hyg 2010; 83: 1352-1355.
9. Chotmongkol V, Sawanyawisuth K, Thavornpitak Y. Corticosteroid treatment of eosinophilic meningitis. Clin Infect Dis 2000; 31: 660-662.
10. Kliks MM, Kroenke K, Hardman JM. Eosinophilic radiculomyeloencephalitis: an angiostrongyliasis outbreak in American Samoa related to ingestion of Achatina fulica snails. Am J Trop Med Hyg 1982; 31: 1114-1122.
11. Lammi MH, Smith VH, Tate RL, Taylor CM. The minimally conscious state and recovery potential: a follow-up study 2 to 5 years after traumatic brain injury. Arch Phys Med Rehabil 2005; 86: 746-754.